Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
China Suspends GSK Tender Qualification Under Dutasteride Ban
Nov 03 2022
•
By
Brian Yang
GSK GETS CHINA BLACKLISTED FOR PUBLIC TENDER DUE TO DUTASTERIDE BAN • Source: Shutterstock
More from China
More from Focus On Asia